Work

A matching-adjusted indirect comparison (MAIC) of zanubrutinib vs venetoclax + ibrutinib in treatment-naive chronic lymphocytic leukemia (CLL)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7436

Authors: Talha Munir, Leyla Mohseninejad, Sheng Xu, Keri Yang, Rhys Williams, Remus Vezan, Nicolas Martinez-Calle

Institutions: Leeds Teaching Hospitals NHS Trust, Nottingham University Hospitals NHS Trust

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417006558

Cites:

Cited by:

Related to: